Cancer immunology, immunotherapy : CII

Keyphrases

Publications

volume 73, number 9, 2024

M Stayoussef, X Weili, A Habel, M Barbirou, S Bedoui, A Attia, Y Omrani, K Zouari, H Maghrebi, W Y Almawi, B Bouhaouala-Zahar, A Larbi, B Yacoubi-Loueslati
Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Koollawat Chupradit, Saitong Muneekaew, Methichit Wattanapanitch
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Claudia Piccinini, Silvia Carloni, Chiara Arienti, Elena Pancisi, Francesca Fanini, Sara Pignatta, Valentina Soldati, Monica Stefanelli, Anna Maria Granato, Giovanni Martinelli, Laura Ridolfi, Massimiliano Petrini
In vitro CAR-T cell killing: validation of the potency assay. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Ibrahim El-Serafi, Isabella Micallef Nilsson, Alina Moter, Zhe Duan, Jonas Mattsson, Isabelle Magalhaes
Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Manon Vounckx, Jens Tijtgat, Latoya Stevens, Iris Dirven, Bart Ilsen, Frederik Vandenbroucke, Steven Raeymaeckers, Karolien Vekens, Ramses Forsyth, Xenia Geeraerts, Ivan Van Riet, Julia Katharina Schwarze, Sandra Tuyaerts, Lore Decoster, Mark De Ridder, Ines Dufait, Bart Neyns
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells in solid tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Changfang Fu, Wenbo Ji, Qianwen Cui, Anling Chen, Haiyan Weng, Nannan Lu, Wulin Yang
GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Manon Vounckx, Jens Tijtgat, Latoya Stevens, Iris Dirven, Bart Ilsen, Frederik Vandenbroucke, Steven Raeymaeckers, Karolien Vekens, Ramses Forsyth, Xenia Geeraerts, Ivan Van Riet, Julia Katharina Schwarze, Sandra Tuyaerts, Lore Decoster, Mark De Ridder, Ines Dufait, Bart Neyns
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells in solid tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Chun-Chia Cheng, Jungshan Chang, Ai-Sheng Ho, Zong-Lin Sie, Cheng-Liang Peng, Chih-Liang Wang, Kapil Dev, Chun-Chao Chang
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Hjalmarsson Eric, Krzysztof Piersiala, Vilma Lagebro, Pedro Farrajota Neves Da Silva, Marianne Petro, Magnus Starkhammar, Alexandra Elliot, Rusana Bark, Gregori Margolin, Susanna Kumlien Georén, Lars-Olaf Cardell
High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Qingjian Xie, Yuan Zeng, Xiangting Zhang, Fujun Yu
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Chun-Chia Cheng, Jungshan Chang, Ai-Sheng Ho, Zong-Lin Sie, Cheng-Liang Peng, Chih-Liang Wang, Kapil Dev, Chun-Chao Chang
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Yuan Tian, Zongxiu Yin, Chi Zhang, Zhuoqi Li, Yuanyuan Wang, Kai Zhang, Feng Chen, Qi Dang
Differences in the risk of immune-related pneumonitis between PD-1 and PD-L1 inhibitors: a meta-analysis according to the new mirror-principle and PRISMA guidelines. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Zongliang Zhang, Nian Yang, Long Xu, Huaqing Lu, Yongdong Chen, Zeng Wang, Qizhong Lu, Kunhong Zhong, Zhixiong Zhu, Guoqing Wang, Hexian Li, Meijun Zheng, Liangxue Zhou, Aiping Tong
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Koollawat Chupradit, Saitong Muneekaew, Methichit Wattanapanitch
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Yuan Tian, Zongxiu Yin, Chi Zhang, Zhuoqi Li, Yuanyuan Wang, Kai Zhang, Feng Chen, Qi Dang
Differences in the risk of immune-related pneumonitis between PD-1 and PD-L1 inhibitors: a meta-analysis according to the new mirror-principle and PRISMA guidelines. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Julie Tsu-Yu Wu, June Corrigan, Chloe Su, Clark Dumontier, Jennifer La, Aparjita Khan, Shipra Arya, Alex H S Harris, Leah Backhus, Millie Das, Nhan V Do, Mary T Brophy, Summer S Han, Michael Kelley, Nathanael R Fillmore
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Zhilang Li, Lisha Ma, Zhaoya Gao, Xiya Wang, Xuan Che, Pengchong Zhang, Yixian Li, Qianjing Zhang, Tianxing Liu, Yuan Sun, Yun Bai, Hongkui Deng
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Ibrahim El-Serafi, Isabella Micallef Nilsson, Alina Moter, Zhe Duan, Jonas Mattsson, Isabelle Magalhaes
Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Shijin Liu, Penglin Wang, Peize Wang, Zhan Zhao, Xiaolin Zhang, Yunlong Pan, Jinghua Pan
Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Zhilang Li, Lisha Ma, Zhaoya Gao, Xiya Wang, Xuan Che, Pengchong Zhang, Yixian Li, Qianjing Zhang, Tianxing Liu, Yuan Sun, Yun Bai, Hongkui Deng
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Shijin Liu, Penglin Wang, Peize Wang, Zhan Zhao, Xiaolin Zhang, Yunlong Pan, Jinghua Pan
Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Julie Tsu-Yu Wu, June Corrigan, Chloe Su, Clark Dumontier, Jennifer La, Aparjita Khan, Shipra Arya, Alex H S Harris, Leah Backhus, Millie Das, Nhan V Do, Mary T Brophy, Summer S Han, Michael Kelley, Nathanael R Fillmore
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Ziena Abdulrahman, Kim E Kortekaas, Marij J P Welters, Mariette I E van Poelgeest, Sjoerd H van der Burg
Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Chun-Chia Cheng, Jungshan Chang, Ai-Sheng Ho, Zong-Lin Sie, Cheng-Liang Peng, Chih-Liang Wang, Kapil Dev, Chun-Chao Chang
Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Ibrahim El-Serafi, Isabella Micallef Nilsson, Alina Moter, Zhe Duan, Jonas Mattsson, Isabelle Magalhaes
Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Carlo Messina, Martina Catalano, Giandomenico Roviello, Annalice Gandini, Marco Maruzzo, Ugo De Giorgi, Paolo Pedrazzoli, Andrea Sbrana, Paolo Andrea Zucal, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Michele Milella, Fabio Catalano, Lucia Fratino, Stefania Pipitone, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Soraru, Veronica Prati, Francesco Atzori, Marilena Di Napoli, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nole, Andrea Malgeri, Marianna Tudini, Francesca Vignani, Alessia Cavo, Alessio Signori, Giuseppe Luigi Banna, Pasquale Rescigno, Sebastiano Buti, Sara Elena Rebuzzi, Giuseppe Fornarini
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. Cancer immunology, immunotherapy : CII 73 (9) (2024)
William Rodin, Louis Szeponik, Tsvetanka Rangelova, Firaol Tamiru Kebede, Tobias Österlund, Patrik Sundström, Stephen Hogg, Yvonne Wettergren, Antonio Cosma, Anders Ståhlberg, Elinor Bexe Lindskog, Marianne Quiding-Järbrink
γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Manon Vounckx, Jens Tijtgat, Latoya Stevens, Iris Dirven, Bart Ilsen, Frederik Vandenbroucke, Steven Raeymaeckers, Karolien Vekens, Ramses Forsyth, Xenia Geeraerts, Ivan Van Riet, Julia Katharina Schwarze, Sandra Tuyaerts, Lore Decoster, Mark De Ridder, Ines Dufait, Bart Neyns
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells in solid tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
William Rodin, Louis Szeponik, Tsvetanka Rangelova, Firaol Tamiru Kebede, Tobias Österlund, Patrik Sundström, Stephen Hogg, Yvonne Wettergren, Antonio Cosma, Anders Ståhlberg, Elinor Bexe Lindskog, Marianne Quiding-Järbrink
γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Julie Tsu-Yu Wu, June Corrigan, Chloe Su, Clark Dumontier, Jennifer La, Aparjita Khan, Shipra Arya, Alex H S Harris, Leah Backhus, Millie Das, Nhan V Do, Mary T Brophy, Summer S Han, Michael Kelley, Nathanael R Fillmore
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Niraj Shrestha, Michael J Dee, Pallavi Chaturvedi, Gilles M Leclerc, Mary Mathyer, Celeste Dufour, Laura Arthur, Michelle Becker-Hapak, Mark Foster, Ethan McClain, Natalia Valderrama Pena, Karen Kage, Xiaoyun Zhu, Varghese George, Bai Liu, Jack Egan, Christian Echeverri, Meng Wang, Lijing You, Lin Kong, Liying Li, Melissa M Berrien-Elliott, Matthew L Cooper, Todd A Fehniger, Peter R Rhode, Hing C Wong
A "Prime and Expand" strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Claudia Piccinini, Silvia Carloni, Chiara Arienti, Elena Pancisi, Francesca Fanini, Sara Pignatta, Valentina Soldati, Monica Stefanelli, Anna Maria Granato, Giovanni Martinelli, Laura Ridolfi, Massimiliano Petrini
In vitro CAR-T cell killing: validation of the potency assay. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Ziena Abdulrahman, Kim E Kortekaas, Marij J P Welters, Mariette I E van Poelgeest, Sjoerd H van der Burg
Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Shijin Liu, Penglin Wang, Peize Wang, Zhan Zhao, Xiaolin Zhang, Yunlong Pan, Jinghua Pan
Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Hjalmarsson Eric, Krzysztof Piersiala, Vilma Lagebro, Pedro Farrajota Neves Da Silva, Marianne Petro, Magnus Starkhammar, Alexandra Elliot, Rusana Bark, Gregori Margolin, Susanna Kumlien Georén, Lars-Olaf Cardell
High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Carlo Messina, Martina Catalano, Giandomenico Roviello, Annalice Gandini, Marco Maruzzo, Ugo De Giorgi, Paolo Pedrazzoli, Andrea Sbrana, Paolo Andrea Zucal, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Michele Milella, Fabio Catalano, Lucia Fratino, Stefania Pipitone, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Soraru, Veronica Prati, Francesco Atzori, Marilena Di Napoli, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nole, Andrea Malgeri, Marianna Tudini, Francesca Vignani, Alessia Cavo, Alessio Signori, Giuseppe Luigi Banna, Pasquale Rescigno, Sebastiano Buti, Sara Elena Rebuzzi, Giuseppe Fornarini
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Qingjian Xie, Yuan Zeng, Xiangting Zhang, Fujun Yu
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 73 (9) (2024)
William Rodin, Louis Szeponik, Tsvetanka Rangelova, Firaol Tamiru Kebede, Tobias Österlund, Patrik Sundström, Stephen Hogg, Yvonne Wettergren, Antonio Cosma, Anders Ståhlberg, Elinor Bexe Lindskog, Marianne Quiding-Järbrink
γδ T cells in human colon adenocarcinomas comprise mainly Vδ1, Vδ2, and Vδ3 cells with distinct phenotype and function. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Zongliang Zhang, Nian Yang, Long Xu, Huaqing Lu, Yongdong Chen, Zeng Wang, Qizhong Lu, Kunhong Zhong, Zhixiong Zhu, Guoqing Wang, Hexian Li, Meijun Zheng, Liangxue Zhou, Aiping Tong
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Yuan Tian, Zongxiu Yin, Chi Zhang, Zhuoqi Li, Yuanyuan Wang, Kai Zhang, Feng Chen, Qi Dang
Differences in the risk of immune-related pneumonitis between PD-1 and PD-L1 inhibitors: a meta-analysis according to the new mirror-principle and PRISMA guidelines. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Zhilang Li, Lisha Ma, Zhaoya Gao, Xiya Wang, Xuan Che, Pengchong Zhang, Yixian Li, Qianjing Zhang, Tianxing Liu, Yuan Sun, Yun Bai, Hongkui Deng
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures. Cancer immunology, immunotherapy : CII 73 (9) (2024)
M Stayoussef, X Weili, A Habel, M Barbirou, S Bedoui, A Attia, Y Omrani, K Zouari, H Maghrebi, W Y Almawi, B Bouhaouala-Zahar, A Larbi, B Yacoubi-Loueslati
Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Joshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, Lydia D Hardowar, Murrium Ahmad, Louise C Wainwright, Adam M McVicar, Victoria A Brentville, Chris J Tinsley, Alan Graham Pockley, Lindy G Durrant, Stéphanie E B McArdle
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Qingjian Xie, Yuan Zeng, Xiangting Zhang, Fujun Yu
The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Hjalmarsson Eric, Krzysztof Piersiala, Vilma Lagebro, Pedro Farrajota Neves Da Silva, Marianne Petro, Magnus Starkhammar, Alexandra Elliot, Rusana Bark, Gregori Margolin, Susanna Kumlien Georén, Lars-Olaf Cardell
High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Changfang Fu, Wenbo Ji, Qianwen Cui, Anling Chen, Haiyan Weng, Nannan Lu, Wulin Yang
GSDME-mediated pyroptosis promotes anti-tumor immunity of neoadjuvant chemotherapy in breast cancer. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Carlo Messina, Martina Catalano, Giandomenico Roviello, Annalice Gandini, Marco Maruzzo, Ugo De Giorgi, Paolo Pedrazzoli, Andrea Sbrana, Paolo Andrea Zucal, Cristina Masini, Emanuele Naglieri, Giuseppe Procopio, Michele Milella, Fabio Catalano, Lucia Fratino, Stefania Pipitone, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Soraru, Veronica Prati, Francesco Atzori, Marilena Di Napoli, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nole, Andrea Malgeri, Marianna Tudini, Francesca Vignani, Alessia Cavo, Alessio Signori, Giuseppe Luigi Banna, Pasquale Rescigno, Sebastiano Buti, Sara Elena Rebuzzi, Giuseppe Fornarini
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Zongliang Zhang, Nian Yang, Long Xu, Huaqing Lu, Yongdong Chen, Zeng Wang, Qizhong Lu, Kunhong Zhong, Zhixiong Zhu, Guoqing Wang, Hexian Li, Meijun Zheng, Liangxue Zhou, Aiping Tong
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Claudia Piccinini, Silvia Carloni, Chiara Arienti, Elena Pancisi, Francesca Fanini, Sara Pignatta, Valentina Soldati, Monica Stefanelli, Anna Maria Granato, Giovanni Martinelli, Laura Ridolfi, Massimiliano Petrini
In vitro CAR-T cell killing: validation of the potency assay. Cancer immunology, immunotherapy : CII 73 (9) (2024)